Shifting from combat to communication
This article was originally published in Scrip
Executive Summary
Hammered by the German government's decision to end free pricing, scrutinised by health technology assessment bodies who appear unconvinced about the value of incremental innovation and plagued by the European Commission's investigation into potentially uncompetitive practices, is the European pharmaceutical industry’s ship in danger of sinking?